OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
Ravi B. Parikh, Samuel U Takvorian, Daniel T. Vader, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 114, Iss. 4, pp. 571-578
Open Access | Times Cited: 13
Ravi B. Parikh, Samuel U Takvorian, Daniel T. Vader, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 114, Iss. 4, pp. 571-578
Open Access | Times Cited: 13
Showing 13 citing articles:
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 5, pp. 409-436
Open Access | Times Cited: 3012
Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 5, pp. 409-436
Open Access | Times Cited: 3012
Effect of the COVID-19 pandemic and lockdown on cancer stage distribution and time to treatment initiation using cancer registry data of the Swiss cantons of Zurich and Zug from 2018 to 2021
Flurina Suter, Miriam Wanner, Andreas Wicki, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Flurina Suter, Miriam Wanner, Andreas Wicki, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Assessment of Changes in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US
Letícia Nogueira, Elizabeth J. Schafer, Qinjin Fan, et al.
JAMA Oncology (2023) Vol. 10, Iss. 1, pp. 109-109
Open Access | Times Cited: 8
Letícia Nogueira, Elizabeth J. Schafer, Qinjin Fan, et al.
JAMA Oncology (2023) Vol. 10, Iss. 1, pp. 109-109
Open Access | Times Cited: 8
Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer
Harlan Pittell, Gregory S. Calip, Amy Pierre, et al.
Breast Cancer Research and Treatment (2024) Vol. 206, Iss. 2, pp. 411-423
Open Access | Times Cited: 3
Harlan Pittell, Gregory S. Calip, Amy Pierre, et al.
Breast Cancer Research and Treatment (2024) Vol. 206, Iss. 2, pp. 411-423
Open Access | Times Cited: 3
Continuity of care for patients with de novo metastatic cancer during the COVID ‐19 pandemic: A population‐based observational study
Ellis Slotman, Feike Weijzen, Heidi P. Fransen, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 10, pp. 1786-1793
Open Access | Times Cited: 1
Ellis Slotman, Feike Weijzen, Heidi P. Fransen, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 10, pp. 1786-1793
Open Access | Times Cited: 1
How did states in the United States adapt their cancer control plan in response to the COVID‐19 pandemic?
Jason Semprini
Public Health Challenges (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Jason Semprini
Public Health Challenges (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period
Natalia Neparidze, Rong Wang, Amer M. Zeidan, et al.
Leukemia (2022) Vol. 36, Iss. 8, pp. 2136-2139
Open Access | Times Cited: 5
Natalia Neparidze, Rong Wang, Amer M. Zeidan, et al.
Leukemia (2022) Vol. 36, Iss. 8, pp. 2136-2139
Open Access | Times Cited: 5
Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care
YiYuan Zhai, Pooja Chopra, David C. Kang, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 769-785
Open Access | Times Cited: 2
YiYuan Zhai, Pooja Chopra, David C. Kang, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 769-785
Open Access | Times Cited: 2
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort study
Rui Fu, Rinku Sutradhar, Qing Li, et al.
CMAJ Open (2023) Vol. 11, Iss. 3, pp. E426-E433
Open Access | Times Cited: 2
Rui Fu, Rinku Sutradhar, Qing Li, et al.
CMAJ Open (2023) Vol. 11, Iss. 3, pp. E426-E433
Open Access | Times Cited: 2
Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration data
Christopher T. Su, Jason C. Chen, Jeremy B. Sussman
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 5, pp. 1035-1039
Closed Access | Times Cited: 1
Christopher T. Su, Jason C. Chen, Jeremy B. Sussman
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 5, pp. 1035-1039
Closed Access | Times Cited: 1
Does COVID ‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital
Florian Quilan, Justine Lequesne, François Cherifi, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 17603-17612
Open Access | Times Cited: 1
Florian Quilan, Justine Lequesne, François Cherifi, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 17603-17612
Open Access | Times Cited: 1
Trends in Low-Value Cancer Care During the COVID-19 Pandemic
Ravi B. Parikh, Yasin Civelek, Pelin Ozluk, et al.
The American Journal of Managed Care (2024) Vol. 30, Iss. 4, pp. 186-190
Open Access
Ravi B. Parikh, Yasin Civelek, Pelin Ozluk, et al.
The American Journal of Managed Care (2024) Vol. 30, Iss. 4, pp. 186-190
Open Access
Impacts of the COVID-19 pandemic on diagnosis of renal cell carcinoma and disease stage at presentation
W.C. Ian Janes, Mitchell G. Fagan, J. Matthew Andrews, et al.
Canadian Urological Association Journal (2023) Vol. 18, Iss. 4
Open Access
W.C. Ian Janes, Mitchell G. Fagan, J. Matthew Andrews, et al.
Canadian Urological Association Journal (2023) Vol. 18, Iss. 4
Open Access
